Echo Street Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,129
| Closed | -$811K | – | 556 |
|
|
2023
Q2 | $811K | Buy |
1,129
+693
| +159% | +$498K | 0.01% | 175 |
|
|
2023
Q1 | $358K | Sell |
436
-174
| -29% | -$143K | ﹤0.01% | 344 |
|
|
2022
Q4 | $440K | Buy |
+610
| New | +$440K | ﹤0.01% | 315 |
|
|
2022
Q3 | – | Sell |
-467
| Closed | -$276K | – | 675 |
|
|
2022
Q2 | $276K | Buy |
+467
| New | +$276K | ﹤0.01% | 445 |
|
|
2022
Q1 | – | Sell |
-1,284
| Closed | -$811K | – | 720 |
|
|
2021
Q4 | $811K | Buy |
1,284
+828
| +182% | +$523K | 0.01% | 295 |
|
|
2021
Q3 | $276K | Sell |
456
-349
| -43% | -$211K | ﹤0.01% | 531 |
|
|
2021
Q2 | $450K | Sell |
805
-244
| -23% | -$136K | ﹤0.01% | 399 |
|
|
2021
Q1 | $496K | Buy |
1,049
+284
| +37% | +$134K | ﹤0.01% | 298 |
|
|
2020
Q4 | $370K | Buy |
+765
| New | +$370K | ﹤0.01% | 296 |
|
|
2020
Q3 | – | Sell |
-627
| Closed | -$391K | – | 318 |
|
|
2020
Q2 | $391K | Buy |
+627
| New | +$391K | ﹤0.01% | 374 |
|